Clinical trial
Esprit BTK Post-Approval Study (Esprit BTK PAS)
NCT06656364 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Esprit BTK Post-Approval Study (Esprit BTK PAS)
- Lead sponsor
- Abbott Medical Devices
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- October 21, 2024
- Completion date
- May 30, 2029
- Enrollment
- 200 (actual)
- Sites
- 39
Conditions
As the registry lists them; a condition with its own page is linked.